Table 2.
Treatment response as assessed by imaging features according to the mRECIST and Recist1.1 criteria in two groups
| Treatment response | mRECIST | RECIST1.1 | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Group. No. (%) | Group. No. (%) | |||||
|
|
|
|||||
| HAIC | TACE | P value | HAIC | TACE | P value | |
| CR | 14 | 14 | - | 0 | 0 | - |
| PR | 14 | 28 | - | 18 | 17 | - |
| SD | 6 | 12 | - | 16 | 37 | - |
| PD | 0 | 7 | - | 0 | 7 | - |
| ORR, % | 82.4 | 68.9 | 0.23 | 52.9 | 27.9 | 0.03 |
| DCR, % | 100.0 | 88.5 | < 0.001 | 100.0 | 88.5 | < 0.001 |
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; ORR: objective response rate; DCR: disease control rate.